BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · IEX Real-Time Price · USD
6.42
-0.08 (-1.23%)
Jul 22, 2024, 10:21 AM EDT - Market open
BrainsWay Employees
BrainsWay had 134 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
134
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$255,634
Profits / Employee
-$12,351
Market Cap
107.17M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Augmedix | 1,430 |
InterCure | 270 |
I-Mab | 220 |
Elutia | 54 |
Journey Medical | 41 |
Regulus Therapeutics | 30 |
Zentek | 24 |
Coya Therapeutics | 8 |
BWAY News
- 5 weeks ago - BrainsWay Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada - GlobeNewsWire
- 6 weeks ago - BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS™ for Depression - GlobeNewsWire
- 7 weeks ago - BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression - GlobeNewsWire
- 2 months ago - BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights - GlobeNewsWire
- 3 months ago - BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024 - GlobeNewsWire
- 3 months ago - BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease - GlobeNewsWire
- 4 months ago - BrainsWay Broadens Partnership with Katie's Way Plus Through Order of an Additional 18 Deep TMS™ Systems - GlobeNewsWire
- 4 months ago - BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights - GlobeNewsWire